Signs and Symptoms with MCC
Major Diagnostic Category 23·Grouped by diagnosis·FY 2027
MS-DRG 947 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 23 (MDC 23) with a Major Complication or Comorbidity (MCC). It maps to 131 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 1.2610 with a geometric mean length of stay of 3.6 days and an arithmetic mean of 5.1 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 1.2610 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 3.6 days (used for transfer payments)
- Average stay:
- 5.1 days (arithmetic mean)
- Post-acute transfer policy:
- Yes (early transfers can be paid less)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
| DRG | Title | Relative weight | Mean stay |
|---|---|---|---|
| 555 | Signs and Symptoms of Musculoskeletal System and Connective Tissue with MCC | 1.2913 | 3.7 days |
| 556 | Signs and Symptoms of Musculoskeletal System and Connective Tissue without MCC | 0.8211 | 2.7 days |
| 947 | Signs and Symptoms with MCC (this page) | 1.2610 | 3.6 days |
| 948 | Signs and Symptoms without MCC | 0.7835 | 2.6 days |
Diagnosis codes (131)
As the principal diagnosis, these ICD-10-CM codes can group to DRG 947. 100% of the codes listed are billable.
- E07.81Sick-euthyroid syndrome
- E79.0Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
- G89.11Acute pain due to trauma
- G89.12Acute post-thoracotomy pain
- G89.18Other acute postprocedural pain
- G89.3Neoplasm related pain (acute) (chronic)
- G93.31Postviral fatigue syndrome
- G93.32Myalgic encephalomyelitis/chronic fatigue syndrome
- G93.39Other post infection and related fatigue syndromes
- P09.1Abnormal findings on neonatal screening for inborn errors of metabolism
- P09.2Abnormal findings on neonatal screening for congenital endocrine disease
- P09.3Abnormal findings on neonatal screening for congenital hematologic disorders
- P09.4Abnormal findings on neonatal screening for cystic fibrosis
- P09.5Abnormal findings on neonatal screening for critical congenital heart disease
- P09.6Abnormal findings on neonatal hearing screening
- P09.8Other abnormal findings on neonatal screening
- P09.9Abnormal findings on neonatal screening, unspecified
- R18.0Malignant ascites
- R18.8Other ascites
- R23.0Cyanosis
- R23.1Pallor
- R23.2Flushing
- R41.0Disorientation, unspecified
- R41.1Anterograde amnesia
- R41.2Retrograde amnesia
- R41.3Other amnesia
- R41.82Altered mental status, unspecified
- R41.9Unspecified symptoms and signs involving cognitive functions and awareness
- R45.83Excessive crying of child, adolescent or adult
- R45.84Anhedonia
- R52Pain, unspecified
- R53.0Neoplastic (malignant) related fatigue
- R53.1Weakness
- R53.2Functional quadriplegia
- R53.81Other malaise
- R53.82Chronic fatigue, unspecified
- R53.83Other fatigue
- R60.0Localized edema
- R60.1Generalized edema
- R60.9Edema, unspecified
- R64Cachexia
- R68.0Hypothermia, not associated with low environmental temperature
- R68.11Excessive crying of infant (baby)
- R68.12Fussy infant (baby)
- R68.81Early satiety
- R68.83Chills (without fever)
- R68.89Other general symptoms and signs
- R70.0Elevated erythrocyte sedimentation rate
- R70.1Abnormal plasma viscosity
- R74.01Elevation of levels of liver transaminase levels
- R74.02Elevation of levels of lactic acid dehydrogenase [LDH]
- R74.8Abnormal levels of other serum enzymes
- R74.9Abnormal serum enzyme level, unspecified
- R77.0Abnormality of albumin
- R77.1Abnormality of globulin
- R77.2Abnormality of alphafetoprotein
- R77.8Other specified abnormalities of plasma proteins
- R77.9Abnormality of plasma protein, unspecified
- R78.1Finding of opiate drug in blood
- R78.2Finding of cocaine in blood
- R78.3Finding of hallucinogen in blood
- R78.4Finding of other drugs of addictive potential in blood
- R78.5Finding of other psychotropic drug in blood
- R78.6Finding of steroid agent in blood
- R78.71Abnormal lead level in blood
- R78.72Abnormal gadolinium level in blood
- R78.79Finding of abnormal level of heavy metals in blood
- R78.89Finding of other specified substances, not normally found in blood
- R78.9Finding of unspecified substance, not normally found in blood
- R79.0Abnormal level of blood mineral
- R79.1Abnormal coagulation profile
- R79.81Abnormal blood-gas level
- R79.82Elevated C-reactive protein (CRP)
- R79.83Abnormal findings of blood amino-acid level
- R79.89Other specified abnormal findings of blood chemistry
- R79.9Abnormal finding of blood chemistry, unspecified
- R82.1Myoglobinuria
- R84.0Abnormal level of enzymes in specimens from respiratory organs and thorax
- R84.1Abnormal level of hormones in specimens from respiratory organs and thorax
- R84.2Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax
- R84.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax
- R84.4Abnormal immunological findings in specimens from respiratory organs and thorax
- R84.5Abnormal microbiological findings in specimens from respiratory organs and thorax
- R84.6Abnormal cytological findings in specimens from respiratory organs and thorax
- R84.7Abnormal histological findings in specimens from respiratory organs and thorax
- R84.8Other abnormal findings in specimens from respiratory organs and thorax
- R84.9Unspecified abnormal finding in specimens from respiratory organs and thorax
- R85.0Abnormal level of enzymes in specimens from digestive organs and abdominal cavity
- R85.1Abnormal level of hormones in specimens from digestive organs and abdominal cavity
- R85.2Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity
- R85.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity
- R85.4Abnormal immunological findings in specimens from digestive organs and abdominal cavity
- R85.5Abnormal microbiological findings in specimens from digestive organs and abdominal cavity
- R85.69Abnormal cytological findings in specimens from other digestive organs and abdominal cavity
- R85.7Abnormal histological findings in specimens from digestive organs and abdominal cavity
- R85.89Other abnormal findings in specimens from digestive organs and abdominal cavity
- R85.9Unspecified abnormal finding in specimens from digestive organs and abdominal cavity
- R87.0Abnormal level of enzymes in specimens from female genital organs
- R87.1Abnormal level of hormones in specimens from female genital organs
- R87.2Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
- R87.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
- R87.4Abnormal immunological findings in specimens from female genital organs
- R87.5Abnormal microbiological findings in specimens from female genital organs
- R87.618Other abnormal cytological findings on specimens from cervix uteri
- R87.619Unspecified abnormal cytological findings in specimens from cervix uteri
- R87.629Unspecified abnormal cytological findings in specimens from vagina
- R87.69Abnormal cytological findings in specimens from other female genital organs
- R87.7Abnormal histological findings in specimens from female genital organs
- R87.89Other abnormal findings in specimens from female genital organs
- R87.9Unspecified abnormal finding in specimens from female genital organs
- R88.0Cloudy (hemodialysis) (peritoneal) dialysis effluent
- R88.8Abnormal findings in other body fluids and substances
- R89.0Abnormal level of enzymes in specimens from other organs, systems and tissues
- R89.1Abnormal level of hormones in specimens from other organs, systems and tissues
- R89.2Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues
- R89.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
- R89.4Abnormal immunological findings in specimens from other organs, systems and tissues
- R89.5Abnormal microbiological findings in specimens from other organs, systems and tissues
- R89.6Abnormal cytological findings in specimens from other organs, systems and tissues
- R89.7Abnormal histological findings in specimens from other organs, systems and tissues
- R89.8Other abnormal findings in specimens from other organs, systems and tissues
- R90.89Other abnormal findings on diagnostic imaging of central nervous system
- R93.89Abnormal findings on diagnostic imaging of other specified body structures
- R93.9Diagnostic imaging inconclusive due to excess body fat of patient
- R97.0Elevated carcinoembryonic antigen [CEA]
- R97.1Elevated cancer antigen 125 [CA 125]
- R97.20Elevated prostate specific antigen [PSA]
- R97.21Rising PSA following treatment for malignant neoplasm of prostate
- R97.8Other abnormal tumor markers
- Z17.21Progesterone receptor positive status
- Z17.22Progesterone receptor negative status
